This webinar provides information on the identification of patients at high risk for progression to active disease. The presenters also discuss challenges for treatment completion, such as co-morbidities, risky behaviors, and other medications that may interfere with treatment.
In this video, viewers follow Tubercules as they learn about TB testing and treatment at the Metro Public Health Department TB Elimination Program. Viewers will also see a range of TB program staff in action, such as TB nurses and case managers.
This poster is intended to encourage health care workers to advise clients that if conditions of tuberculosis (TB) symptoms last more than 2-3 weeks, to avoid group settings and see a medical provider immediately.
In this video, TB survivors talk about the importance of latent TB infection testing and treatment. A TB control professional also describes their experience helping patients with latent TB infection treatment.
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
This report presents summary data for U.S. TB cases reported to the Division of TB Elimination, CDC, during 2018.
This 90-minute webinar is aimed towards TB program staff interested in learning about the 2019 CDC/NTCA recommendations on TB screening, testing, and treatment of U.S. Health Care Personnel.
This fact sheet contains information on TB testing and treatment for pregnant or breastfeeding mothers. The resource also contains information on the differences between TB disease and latent TB infection.
This resources summarizes TB screening and testing information for health care personnel and caregivers. Topics covered include screening and testing upon hire, testing after a TB exposure event, and annual training and screening.
The TB Stigma Assessment Tool was created to help countries recognize why, when and where stigma happens, and understand the impact stigma has. By using the tool, countries and their national TB programs can be better equipped to develop targeted health and human rights actions to address stigma.
